ResMed (NYSE:RMD – Get Free Report) had its price target reduced by stock analysts at Piper Sandler from $233.00 to $225.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “neutral” rating on the medical equipment provider’s stock. Piper Sandler’s price target points to a potential upside of 7.51% from the [...]
Piper Sandler Lowers ResMed (NYSE:RMD) Price Target to $225.00
